Part of Amgen's tax savings to go into $300M U.S. biologics plant, 300 new jobs

Date Published02/06/2018
Author NameEric Palmer
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Amgen
Parent companyAmgen Inc
Type of work Manufacturing
Reshoring category:Reshoring
Total number of jobs (added or to be added):300
Capital investment ($):300
Country(ies) from which reshored:Singapore
If relevant, work nearshored to:-
Product(s) reshoredbiotech
What domestic positive factors made reshoring more attractive?Customer responsiveness improvement, Government Incentives, Higher productivity
Find Reshoring Articles